Followers | 465 |
Posts | 18683 |
Boards Moderated | 3 |
Alias Born | 05/05/2012 |
Wednesday, May 20, 2015 10:51:29 AM
Johnson & Johnson will develop and sell Achillion Pharmaceuticals Inc.'s hepatitis C drugs and invest $225 million in Achillion, in a combined deal valued at about $1.1 billion, the companies said on Tuesday.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM